Sabina Vennarini

IRCCS National Cancer Institute Foundation, Italy

Title: TBA

---

Biography

Dr. Sabina Vennarini is a senior radiation oncologist and internationally recognized expert in pediatric radiation oncology and proton therapy. She graduated with honors in Medicine and Surgery from the University of Bologna and subsequently obtained specialist qualifications with highest distinction in both Radiology (Neuroradiology track) and Radiation Oncology. She also earned the European Interuniversity Diploma in Pediatric Oncology (DIUOP) from Paris-Sud University and completed advanced training in Healthcare Economics and Management at Sapienza University of Rome. She is currently pursuing a PhD in Oncology, Hematology, and Pathology at the University of Bologna.

Throughout her career, Dr. Vennarini has completed advanced clinical and research fellowships at leading international institutions, including the Institut Curie (Paris), Paul Scherrer Institute (Switzerland), University of Pennsylvania, and Children's Hospital of Philadelphia (USA). She was appointed Adjunct Assistant Professor in the Department of Radiation Oncology at the University of Pennsylvania, where she contributed to pioneering research in pediatric proton therapy and cardiac-sparing radiation techniques.

Since 2021, she has served as Head of the Pediatric Radiation Oncology Unit and Vice Director of the Radiation Oncology Department at the National Cancer Institute Foundation (IRCCS) in Milan, Italy. She is also Consultant and Head of Pediatric Proton Therapy at the National Center for Oncological Hadrontherapy (CNAO) in Pavia.

Dr. Vennarini is actively involved in several international pediatric oncology and radiotherapy organizations, including SIOP, AIEOP, and the International Atomic Energy Agency (IAEA). She serves as a reviewer and editor for multiple international scientific journals and has authored numerous scientific publications in the fields of pediatric oncology, radiation oncology, and proton therapy.

Her clinical and research interests focus on pediatric solid tumors, central nervous system tumors, proton therapy, treatment-related toxicity reduction, quality of life in cancer survivors, and the development of innovative multidisciplinary treatment protocols for children and adolescents with cancer.

Abstract